Citadel Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$553K Buy
+24,500
New +$563K ﹤0.01% 9055
2025
Q4
Sell
-16,300
Closed -$429K 13101
2025
Q3
$429K Buy
+16,300
New +$419K ﹤0.01% 9506
2025
Q2
Sell
-71,200
Closed -$1.77M 13348
2025
Q1
$1.77M Buy
71,200
+14,600
+26% +$348K ﹤0.01% 5759
2024
Q4
$1.28M Sell
56,600
-15,900
-22% -$345K ﹤0.01% 6528
2024
Q3
$1.54M Buy
72,500
+32,800
+83% +$646K ﹤0.01% 5999
2024
Q2
$758K Buy
39,700
+12,100
+44% +$247K ﹤0.01% 7168
2024
Q1
$532K Buy
27,600
+19,700
+249% +$390K ﹤0.01% 8255
2023
Q4
$165K Sell
7,900
-9,200
-54% -$177K ﹤0.01% 10244
2023
Q3
$368K Sell
17,100
-11,300
-40% -$274K ﹤0.01% 8724
2023
Q2
$680K Buy
28,400
+8,200
+41% +$188K ﹤0.01% 7253
2023
Q1
$429K Buy
20,200
+10,600
+110% +$203K ﹤0.01% 8617
2022
Q4
$157K Sell
9,600
-1,800
-16% -$26.7K ﹤0.01% 10548
2022
Q3
$160K Sell
11,400
-800
-7% -$15.1K ﹤0.01% 10636
2022
Q2
$304K Buy
+12,200
New +$365K ﹤0.01% 9770
2021
Q2
Sell
-7,700
Closed -$284K 13902
2021
Q1
$284K Buy
+7,700
New +$291K ﹤0.01% 10983

Other funds holding FMS

Citadel Advisors's FMS Position: Q1 2026 in Review

Citadel Advisors increased its Fresenius Medical Care (FMS) stake by 99% in Q1 2026, buying an estimated $645K and bringing the position to 56,578 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #7123.

Citadel Advisors first reported a position in FMS in Q2 2016 and has held it in 36 quarters since. The position peaked at $16.3M in Q3 2022. 219 funds tracked by Wall St. Rank hold FMS as of Q1 2026.

  • Citadel Advisors held 56,578 shares of Fresenius Medical Care worth $1.28M as of Q1 2026.
  • Citadel Advisors bought 28,089 Fresenius Medical Care shares in Q1 2026, an estimated $645K.
  • Fresenius Medical Care made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7123 holding.
  • Citadel Advisors first reported a position in Fresenius Medical Care in Q2 2016 and has held it in 36 quarters since.
  • Citadel Advisors's Fresenius Medical Care position peaked at $16.3M in Q3 2022.
  • 219 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.